As expected, we found that the expression of gp130 was significantly decreased after Akirin2 knockdown, indicating that Akirin2 enhances angiogenesis in CCA through activating the IL-6/gp130/STAT3/VEGFA axis. Here, AKIRIN2 is linked to cholangiocarcinoma.